Gene: NKAIN4
Official Full Name: sodium/potassium transporting ATPase interacting 4provided by HGNC
Gene Summary: NKAIN4 is a member of a family of mammalian proteins (see NKAIN1; MIM 612871) with similarity to Drosophila Nkain and interacts with the beta subunit of Na,K-ATPase (ATP1B1; MIM 182330) (Gorokhova et al., 2007 [PubMed 17606467]).[supplied by OMIM, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26767 | NKAIN4 Knockout cell line (A549) | Human | NKAIN4 | 1:3~1:4 | Negative | Online Inquiry |
NKAIN4 Gene Knockout Cell Lines represent a cutting-edge tool for molecular and cellular biology research, designed specifically to facilitate the study of the NKAIN4 (Na+/K+-ATPase interacting protein 4) gene's function in physiological and pathological contexts. These genetically modified cell lines have undergone a rigorous knockout process, effectively disrupting the NKAIN4 gene. By eliminating the expression of this critical component, researchers can observe changes in cellular behavior, ion transport, and signaling pathways influenced by the Na+/K+ ATPase complex, among other functions.
The primary mechanism of these knockout cell lines involves CRISPR-Cas9 technology, which introduces specific double-strand breaks in the NKAIN4 gene, leading to insertions or deletions that result in gene inactivation. Researchers utilizing these cell lines can investigate how NKAIN4 modulates cellular mechanisms, including electrolyte homeostasis and cell proliferation, paving the way for novel therapeutic interventions.
In scientific settings, NKAIN4 Gene Knockout Cell Lines are invaluable for studies focused on cardiovascular diseases, metabolic syndromes, and neuromuscular disorders where aberrant ion transport plays a crucial role. The ability to observe the resultant phenotypic changes provides critical insights into disease mechanisms, making these cell lines essential for drug development and the validation of therapeutic targets.
Compared to traditional gene silencing methods, such as RNA interference, the NKAIN4 gene knockout approach offers a permanent and heritable alteration, allowing for a more stable and long-term study of gene function. Researchers will appreciate the specificity and efficiency of this method, reducing off-target effects and improving experimental reliability.
For dedicated researchers and clinicians, the NKAIN4 Gene Knockout Cell Lines present an unparalleled opportunity to deepen our understanding of ion transport-related diseases. Our commitment to quality and innovation ensures these cell lines are rigorously characterized and validated to meet the highest research standards, positioning us as trusted partners in advancing biological discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.